In addition, p-DCB with EDCs activity potentially lead to deregulate pancreatic islet beta-cell function, development of peripheral Insulin resistance (IR), insulin production, beta-cell mass (compensatory hyperplasia/hypertrophy of beta cells) and impaired insulin output, insulin signaling, and increasing cell apoptosis [45, 46]. This evidence concerns the gene INS and Insulin resistance.